Loeb, Talia A.
Murray, Sarah M.
Cooney, Erin E.
Poteat, Tonia
Althoff, Keri N.
Cannon, Christopher M.
Schneider, Jason S.
Mayer, Kenneth H.
Haw, J. Sonya
Wawrzyniak, Andrew J.
Radix, Asa E.
Malone, Jowanna
Adams, Dee
Stevenson, Megan
Reisner, Sari L.
Wirtz, Andrea L.
,
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the National Institute of Child Health and Human Development of the National Institutes of Health (UG3/UH3AI133669)
HIV/AIDS, Hepatitis, STD, and TB Administration (HAHSTA), Washington DC Department of Health
Article History
Received: 4 October 2023
Accepted: 13 January 2024
First Online: 20 January 2024
Declarations
:
: The parent study has been approved by the Johns Hopkins School of Medicine Single Institutional Review Board. This secondary data analysis was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board. All participants provided informed consent for participation in the study.
: Not applicable.
: KNA is a consultant for the All of Us Research Program. TP is a consultant for ViiV Healthcare and received an honorarium for a lecture provided to Merck & Co staff. All other authors have no conflicts of interest or competing interests to declare.